Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 5
2005 2
2006 2
2007 1
2008 2
2009 2
2010 2
2011 2
2012 4
2013 3
2014 7
2015 4
2016 4
2017 4
2018 8
2019 12
2020 6
2021 7
2022 8
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.
Fan H, Xia S, Xiang J, Li Y, Ross MO, Lim SA, Yang F, Tu J, Xie L, Dougherty U, Zhang FQ, Zheng Z, Zhang R, Wu R, Dong L, Su R, Chen X, Althaus T, Riedell PA, Jonker PB, Muir A, Lesinski GB, Rafiq S, Dhodapkar MV, Stock W, Odenike O, Patel AA, Opferman J, Tsuji T, Matsuzaki J, Shah H, Faubert B, Elf SE, Layden B, Bissonnette BM, He YY, Kline J, Mao H, Odunsi K, Gao X, Chi H, He C, Chen J. Fan H, et al. Among authors: matsuzaki j. Nature. 2023 Nov;623(7989):1034-1043. doi: 10.1038/s41586-023-06749-3. Epub 2023 Nov 22. Nature. 2023. PMID: 37993715 Free PMC article.
Magnetoencephalography Research in Pediatric Autism Spectrum Disorder.
Green HL, Edgar JC, Matsuzaki J, Roberts TPL. Green HL, et al. Among authors: matsuzaki j. Neuroimaging Clin N Am. 2020 May;30(2):193-203. doi: 10.1016/j.nic.2020.01.001. Epub 2020 Mar 27. Neuroimaging Clin N Am. 2020. PMID: 32336406 Free PMC article. Review.
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.
Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal BH, Dy GK, Ito F. Abdelfatah E, et al. Among authors: matsuzaki j. Cancer Res Commun. 2023 Mar 30;3(3):510-520. doi: 10.1158/2767-9764.CRC-22-0383. eCollection 2023 Mar. Cancer Res Commun. 2023. PMID: 37009132 Free PMC article.
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Vylegzhanina AV, Bespalov IA, Novototskaya-Vlasova KA, Hall BM, Gleiberman AS, Yu H, Leontieva OV, Leonova KI, Kurnasov OV, Osterman AL, Dy GK, Komissarov AA, Vasilieva E, Gehlhausen J, Iwasaki A, Ambrosone CB, Tsuji T, Matsuzaki J, Odunsi K, Andrianova EL, Gudkov AV. Vylegzhanina AV, et al. Among authors: matsuzaki j. Cancer Res Commun. 2023 Nov 8;3(11):2256-2267. doi: 10.1158/2767-9764.CRC-23-0289. Cancer Res Commun. 2023. PMID: 37870410 Free PMC article.
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.
Mohammadpour H, Tsuji T, MacDonald CR, Sarow JL, Rosenheck H, Daneshmandi S, Choi JE, Qiu J, Matsuzaki J, Witkiewicz AK, Attwood K, Blazar BR, Odunsi K, Repasky EA, McCarthy PL. Mohammadpour H, et al. Among authors: matsuzaki j. Cell Rep. 2023 Mar 28;42(3):112250. doi: 10.1016/j.celrep.2023.112250. Epub 2023 Mar 15. Cell Rep. 2023. PMID: 36924493 Free PMC article.
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Odunsi K, Qian F, Lugade AA, Yu H, Geller MA, Fling SP, Kaiser JC, Lacroix AM, D'Amico L, Ramchurren N, Morishima C, Disis ML, Dennis L, Danaher P, Warren S, Nguyen VA, Ravi S, Tsuji T, Rosario S, Zha W, Hutson A, Liu S, Lele S, Zsiros E, McGray AJR, Chiello J, Koya R, Chodon T, Morrison CD, Putluri V, Putluri N, Mager DE, Gunawan R, Cheever MA, Battaglia S, Matsuzaki J. Odunsi K, et al. Among authors: matsuzaki j. Sci Transl Med. 2022 Mar 16;14(636):eabg8402. doi: 10.1126/scitranslmed.abg8402. Epub 2022 Mar 16. Sci Transl Med. 2022. PMID: 35294258 Free PMC article.
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells.
Dong B, Obermajer N, Tsuji T, Matsuzaki J, Bonura C, Withers H, Long M, Chavel C, Olejniczak SH, Minderman H, Edwards RP, Storkus WJ, Romero P, Kalinski P. Dong B, et al. Among authors: matsuzaki j. Res Sq [Preprint]. 2023 Oct 19:rs.3.rs-3399211. doi: 10.21203/rs.3.rs-3399211/v1. Res Sq. 2023. PMID: 37886562 Free PMC article. Preprint.
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Want MY, Tsuji T, Singh PK, Thorne JL, Matsuzaki J, Karasik E, Gillard B, Cortes Gomez E, Koya RC, Lugade A, Odunsi K, Battaglia S. Want MY, et al. Among authors: matsuzaki j. J Immunother Cancer. 2021 Feb;9(2):e001374. doi: 10.1136/jitc-2020-001374. J Immunother Cancer. 2021. PMID: 33589522 Free PMC article.
Multisite Study of Evoked Potentials in Rett Syndrome.
Saby JN, Benke TA, Peters SU, Standridge SM, Matsuzaki J, Cutri-French C, Swanson LC, Lieberman DN, Key AP, Percy AK, Neul JL, Nelson CA, Roberts TPL, Marsh ED. Saby JN, et al. Among authors: matsuzaki j. Ann Neurol. 2021 Apr;89(4):790-802. doi: 10.1002/ana.26029. Epub 2021 Feb 4. Ann Neurol. 2021. PMID: 33480039 Free PMC article.
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Zangari B, Tsuji T, Matsuzaki J, Mohammadpour H, Eppolito C, Battaglia S, Ito F, Chodon T, Koya R, Robert McGray AJ, Odunsi K. Zangari B, et al. Among authors: matsuzaki j. Cancer Immunol Immunother. 2022 Dec;71(12):2881-2898. doi: 10.1007/s00262-022-03197-2. Epub 2022 Apr 23. Cancer Immunol Immunother. 2022. PMID: 35460379 Free PMC article.
85 results